{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:57:01Z","timestamp":1760821021856,"version":"3.41.2"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02181","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T04:37:26Z","timestamp":1537936646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Beatriz","family":"D\u00edaz-Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Diaz-Bulnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyes","family":"Carvajal Palao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n M.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Corte-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Moris de la Tassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Suarez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the international society for heart and lung transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transpl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1016\/j.healun.2005.01.011","article-title":"Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin","volume":"24","author":"Lehmkuhl","year":"2005"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1016\/j.healun.2005.01.021","article-title":"Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna","volume":"24","author":"Zuckermann","year":"2005","journal-title":"J Heart Lung Transpl."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/01.tp.0000290686.68910.bd","article-title":"A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus","volume":"84","author":"Hill","year":"2007","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transpl."},{"key":"B6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transpl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1432-2277.2009.00940.x","article-title":"Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study","volume":"23","author":"Ross","year":"2010","journal-title":"Transpl Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","article-title":"Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study","volume":"31","author":"Potena","year":"2012","journal-title":"J Heart Lung Transpl."},{"key":"B10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/TP.0000000000001945","article-title":"Optimizing the safety profile of everolimus by delayed initiation in de novo heart transplant recipients: results of the prospective randomized study EVERHEART","volume":"102","author":"Potena","year":"2018","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/ajt.12208","article-title":"Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice","volume":"13","author":"Masetti","year":"2013","journal-title":"Am J Transpl."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time","volume":"36","author":"Chambers","year":"2017","journal-title":"J Heart Lung Transpl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1600-6143.2009.02832.x","article-title":"The multifunctional role of mTOR in innate immunity: implications for transplant immunity","volume":"9","author":"S\u00e4emann","year":"2009","journal-title":"Am J Transpl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1681\/ASN.2010040351","article-title":"The evolving role of mTOR inhibition in transplantation tolerance","volume":"22","author":"McMahon","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.it.2016.08.009","article-title":"mTOR-mediated regulation of dendritic cell differentiation and function","volume":"37","author":"Sukhbaatar","year":"2016","journal-title":"Trends Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.4049\/jimmunol.1000296","article-title":"A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation","volume":"185","author":"Haidinger","year":"2010","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/ni.3438","article-title":"Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation","volume":"17","author":"Pollizzi","year":"2016","journal-title":"Nat Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8? T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.immuni.2011.04.006","article-title":"A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity","volume":"34","author":"Li","year":"2011","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.transproceed.2010.07.045","article-title":"Number of peripheral blood regulatory T cells and lymphocyte activation at 3 months after conversion to mTOR inhibitor therapy","volume":"42","author":"San Segundo","year":"2010","journal-title":"Transplant Proc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trim.2016.05.004","article-title":"Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+ regulatory T cells in heart transplantation","volume":"38","author":"Mirza","year":"2016","journal-title":"Transpl Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.20071477","article-title":"The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells","volume":"205","author":"Haxhinasto","year":"2008","journal-title":"J Exp Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cyto.a.22351","article-title":"From \u201ctruly na\u00efve\u201d to \u201cexhausted senescent\u201d T cells: when markers predict functionality","volume":"85","author":"Larbi","year":"2014","journal-title":"Cytometry A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","article-title":"CD4+ CD25+ CD127low\/\u2212 T cells: a more specific Treg population in human peripheral blood","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cei.12804","article-title":"Phenotypical characterization of regulatory T cells in humans and rodents","volume":"185","author":"Rodr\u00edguez-Perea","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3389\/fimmu.2015.00547","article-title":"Targeting CD8 T-cell metabolism in transplantation","volume":"6","author":"Yap","year":"2015","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","volume":"254","author":"Aktas","year":"2009","journal-title":"Cell Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e56931","DOI":"10.1371\/journal.pone.0056931","article-title":"DNA methylation dynamics in blood after hematopoietic cell transplant","volume":"8","author":"Rodriguez","year":"2013","journal-title":"PLOS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4161\/epi.25201","article-title":"Epigenetic modulation of the immune function: a potential target for tolerance","volume":"8","author":"Su\u00e1rez-\u00c1lvarez","year":"2013","journal-title":"Epigenetics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.healun.2016.02.007","article-title":"Clinical potential of DNA methylation in organ transplantation","volume":"35","author":"Peters","year":"2016","journal-title":"J Heart Lung Transpl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/TP.0b013e31825306ff","article-title":"Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection","volume":"94","author":"Betjes","year":"2012","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e80601","DOI":"10.1371\/journal.pone.0080601","article-title":"Increased numbers of circulating CD8 effector memory T cells before transplantation enhance the risk of acute rejection in lung transplant recipients","volume":"8","author":"San Segundo","year":"2013","journal-title":"PLoS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/ajt.14410","article-title":"Mechanistic sharing between NK cells in ABMR and effector T cells in TCMR","volume":"18","author":"Parkes","year":"2018","journal-title":"Am J Transpl."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2017.02.036","article-title":"CD8+ effector memory T cells induce acute rejection of allogeneic heart retransplants in mice possibly through activating expression of inflammatory cytokines","volume":"355","author":"Du","year":"2017","journal-title":"Exp Cell Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1111\/j.1600-6143.2010.03302.x","article-title":"Comparative transcriptional and phenotypic peripheral blood analysis of kidney recipients under cyclosporin A or sirolimus monotherapy","volume":"10","author":"Brouard","year":"2010","journal-title":"Am J Transpl."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/TP.0000000000000108","article-title":"Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells","volume":"97","author":"Demmers","year":"2014","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fimmu.2013.00046","article-title":"The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs","volume":"4","author":"Neudoerfl","year":"2013","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbmt.2010.08.014","article-title":"Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen","volume":"17","author":"Ohata","year":"2011","journal-title":"Biol Blood Marrow Transpl."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/j.1600-6143.2010.03242.x","article-title":"Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype","volume":"10","author":"Eissens","year":"2010","journal-title":"Am J Transpl."},{"key":"B45","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4049\/jimmunol.1601102","article-title":"Epigenetic networks regulate the transcriptional program in memory and terminally differentiated CD8+ T cells","volume":"198","author":"Rodriguez","year":"2017","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/j.1600-6143.2011.03633.x","article-title":"Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome","volume":"11","author":"Bestard","year":"2011","journal-title":"Am J Transpl."},{"key":"B47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tig.2012.06.005","article-title":"DNA methylation: a promising landscape for immune system-related diseases","volume":"28","author":"Suarez-Alvarez","year":"2012","journal-title":"Trends Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13148-016-0288-0","article-title":"Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation","volume":"8","author":"Boer","year":"2016","journal-title":"Clin Epigenetics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/eji.1830240136","article-title":"Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation","volume":"24","author":"Legros-Ma\u00efda","year":"1994","journal-title":"Eur J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cei.12669","article-title":"Oscillatory mTOR inhibition and Treg increase in kidney transplantation","volume":"182","author":"Sabbatini","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2016.05.005","article-title":"Differential effects of inhibitors of the PI3K\/mTOR pathway on the expansion and functionality of regulatory T cells","volume":"168","author":"Huijts","year":"2016","journal-title":"Clin Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clinre.2017.10.001","article-title":"Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity","volume":"42","author":"Ghazal","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.transproceed.2014.11.026","article-title":"Effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients","volume":"47","author":"D\u00edaz","year":"2015","journal-title":"Transplant Proc."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02181\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T04:37:30Z","timestamp":1537936650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02181\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2018.02181"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02181","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"article-number":"2181"}}